May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin disease, can help reduce coronary plaque.
SCAI
This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies.
-
-
May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented as late-breaking...
-
May 10, 2018 — A new consensus document has been issued to guide the optimal use of ionizing radiation in cardiovascular imaging.
-
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiovascular Therapeutics (TCT).
Photo courtesy of the American Heart Association
News | Atrial Fibrillation | May 15, 2018
May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception...
News | Peripheral Artery Disease (PAD) | May 15, 2018
May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to...
News | Cath Lab | May 15, 2018
May 15, 2018 — Revised guidelines incorporating new data on discharge criteria for patients undergoing elective...
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal...
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.
Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin...
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology | May 14, 2018
May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-...
The Medtronic Endeavor drug-eluting stent was used in the PERSPECTIVE trial to test its durability in chronic total occlusions (CTOs).
News | Chronic Total Occlusion (CTO) | May 14, 2018
May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary...
News | Peripheral Artery Disease (PAD) | May 14, 2018
May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the...
News | Chronic Total Occlusion (CTO) | May 14, 2018
May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total...
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients...
Richard Schatz, M.D., (center) research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a 2018 SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program, Sidra Medical and Research Center, Doha, Qatar, who has been active in new device technologies for structural heart disease.
Feature | SCAI | May 14, 2018
Here is an aggregation of all the news and late-breaking studies presented at the 2018...
News | Heart Valve Technology | May 11, 2018
May 11, 2018 — A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in...
News | Pulmonary Embolism | May 11, 2018
May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking...
News | May 11, 2018
May 11, 2018 — Two studies examining seasonal variations in cardiac-related hospitalizations, specifically...
